Search research articles
Contact Us
Filters
Showing results (731-740 of 803) with videos related to
Page
of 81
Sort By:
BMC Public Health
|
January 30, 2016
The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial
K S Smith, J M Kaldor, J S Hocking, et al.
Open Forum Infectious Diseases
|
October 29, 2020
Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience
Markos Kalligeros, Karen T Tashima, Evangelia K Mylona, et al.
The New England Journal of Medicine
|
May 15, 2007
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Suzanne M Garland, Mauricio Hernandez-Avila, Cosette M Wheeler, et al.
The Lancet. Microbe
|
March 27, 2025
Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis
Teck-Phui Chua, Lenka A Vodstrcil, Gerald L Murray, et al.
Plos One
|
June 5, 2012
Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristics
Jennifer Walker, Sepehr N Tabrizi, Christopher K Fairley, et al.
The Journal of Trauma and Acute Care Surgery
|
February 7, 2022
The public health burden of geriatric trauma: Analysis of 2,688,008 hospitalizations from Centers for Medicare and Medicaid Services inpatient claims
Samir M Fakhry, Yan Shen, Saptarshi Biswas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 10, 2013
Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women
Jennifer Walker, Christopher K Fairley, Catriona S Bradshaw, et al.
In Vivo (Athens, Greece)
|
January 1, 2022
Prevalence and Determinants of Vaginal Infection With Human Papillomavirus Among Female University Students in Vietnam
Nguyen VAN Trang, Kiesha Prem, Zheng Quan Toh, et al.
Vaccine
|
July 20, 2021
Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction
Hannah Shilling, Suzanne M Garland, Steph Atchison, et al.
Papillomavirus Research (Amsterdam, Netherlands)
|
November 5, 2018
Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea
Pamela J Toliman, John M Kaldor, Steven G Badman, et al.
Page
of 81
Search research articles
Search
Showing results (731-740 of 803) with videos related to
Sort By:
Page
of 81
BMC Public Health
|
January 30, 2016
The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial
K S Smith, J M Kaldor, J S Hocking, et al.
Open Forum Infectious Diseases
|
October 29, 2020
Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience
Markos Kalligeros, Karen T Tashima, Evangelia K Mylona, et al.
The New England Journal of Medicine
|
May 15, 2007
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Suzanne M Garland, Mauricio Hernandez-Avila, Cosette M Wheeler, et al.
The Lancet. Microbe
|
March 27, 2025
Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis
Teck-Phui Chua, Lenka A Vodstrcil, Gerald L Murray, et al.
Plos One
|
June 5, 2012
Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristics
Jennifer Walker, Sepehr N Tabrizi, Christopher K Fairley, et al.
The Journal of Trauma and Acute Care Surgery
|
February 7, 2022
The public health burden of geriatric trauma: Analysis of 2,688,008 hospitalizations from Centers for Medicare and Medicaid Services inpatient claims
Samir M Fakhry, Yan Shen, Saptarshi Biswas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 10, 2013
Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women
Jennifer Walker, Christopher K Fairley, Catriona S Bradshaw, et al.
In Vivo (Athens, Greece)
|
January 1, 2022
Prevalence and Determinants of Vaginal Infection With Human Papillomavirus Among Female University Students in Vietnam
Nguyen VAN Trang, Kiesha Prem, Zheng Quan Toh, et al.
Vaccine
|
July 20, 2021
Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction
Hannah Shilling, Suzanne M Garland, Steph Atchison, et al.
Papillomavirus Research (Amsterdam, Netherlands)
|
November 5, 2018
Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea
Pamela J Toliman, John M Kaldor, Steven G Badman, et al.
Page
of 81